Thermometers that read body temperature via the forehead have become a common sight throughout the pandemic, but whether they always spot a fever may depend on the color of someone’s skin. In a new study, researchers found that, similar to problems seen with pulse oximeters, temporal thermometers are less accurate at detecting fevers in Black… read on > read on >
A little about: Weekly Sauce
All Sauce from Weekly Sauce:
Do Taxes on Soda Really Lower Sugar Intake?
New research suggests that good intentions may not always be enough when it comes to public health. According to the study of the consequences of Philadelphia’s 2017 tax on sugar-sweetened drinks, people bought more candy and cookies or did more shopping outside city limits, to both avoid the tax and satisfy their sweet tooth cravings.… read on > read on >
Another Reason to Get the Flu Shot: Lowered Risk for Stroke
As flu season approaches, a new study is pointing to a possible bonus from vaccination: a lower risk of stroke. Researchers in Spain found that among nearly 86,000 middle-aged and older adults, those who got their annual flu shot were less likely to suffer an ischemic stroke over the next year. Ischemic strokes, which account… read on > read on >
Stress Before COVID Infection Could Raise Odds for Long COVID
As scientists around the world investigate why long COVID strikes some and not others, a new study finds that suffering psychological distress prior to COVID-19 infection may increase the chances of getting the lingering condition. Researchers from the Harvard T.H. Chan School of Public Health in Boston said they were surprised at the strength of… read on > read on >
AHA News: Her Research Is Getting Worldwide Attention. But For Now, She Needs to Finish High School.
THURSDAY, Sept. 8, 2022 (American Heart Association News) — Explaining her research, Maria Balhara sounds like a typical scientist: She had a hypothesis. She recruited participants to evaluate. She analyzed the data. Soon, she’ll present her work at major scientific conferences. This might be routine stuff for a professor or graduate student. For a 16-year-old… read on > read on >
Experimental Drug Shows Promise Against Lupus
An experimental drug that has been shown to treat rashes in people with lupus may also help with lupus-related joint pain. Affecting as many as 1.5 million people in the United States, lupus is an autoimmune disease in which the body’s immune system misfires against its own joints, skin, brain, lungs, kidneys and blood vessels.… read on > read on >
Too Little Exercise, Too Much Sitting Could Raise Breast Cancer Risk
Sitting on the couch or behind a desk could be increasing your risk of breast cancer, a new genetics-driven study suggests. People more likely to engage in physical activity based on their DNA had a 41% lower risk of invasive breast cancer, researchers report. Previous research also has shown a link between exercise and reduced… read on > read on >
Nurse Practitioners Are Filling the Gap in U.S. Psychiatric Care
While mental health care has become a full-blown crisis in the United States, a new study finds that psychiatric nurse practitioners are helping to fill the gap. The researchers discovered that the mental health system in the United States has become increasingly reliant on this particular category of specialists to meet the needs of Medicare… read on > read on >
Vitamin D Supplements Won’t Shield You From COVID-19, Studies Find
While vitamin D got some attention early in the pandemic, it does not reduce the risk of either COVID-19 or other respiratory infections, two new clinical trials found. Both studies, one done in the United Kingdom and the other in Norway, found that boosting levels of vitamin D in adults during the pandemic didn’t help… read on > read on >
In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in 2nd Review
THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis). The FDA is not obligated to follow its advisors’ recommendations, though it usually does. Wednesday’s vote was 7-2 for approval. The same panel… read on > read on >